CCC Intelligent Solutions (US:CCCS)2025-10-30 11:15Financial Performance - Total revenue for Q3 2025 was $267.1 million, a 12% increase from $238.5 million in Q3 2024[3] - Adjusted EBITDA for Q3 2025 was $110.1 million, reflecting an 8% growth compared to $101.6 million in Q3 2024[7] - GAAP net loss for Q3 2025 was $2.0 million, down from a net income of $4.1 million in Q3 2024[7] - Free cash flow for Q3 2025 was $78.6 million, compared to $49.4 million in Q3 2024, marking a significant increase[5] - Gross profit for Q3 2025 was $192,973,000, an increase from $183,420,000 in Q3 2024, representing a growth of 8.5%[26] - Adjusted operating income for the nine months ended September 30, 2025, was $272,627,000, compared to $261,261,000 in the same period of 2024, indicating a growth of 4.4%[28] - The adjusted net income for the nine months ended September 30, 2025, was $172,766,000, slightly down from $173,557,000 in the same period of 2024, a decrease of 0.5%[30] - The adjusted net income per share for Q3 2025 was $0.09, consistent with $0.10 in Q3 2024[30] Cash Flow and Assets - CCC had $97.1 million in cash and cash equivalents and $993.5 million in total debt as of September 30, 2025[5] - Cash and cash equivalents decreased to $97.14 million as of September 30, 2025, down from $398.98 million at the beginning of the period[24] - Net cash provided by operating activities for the nine months ended September 30, 2025, was $196.32 million, up from $170.24 million in the same period of 2024[24] Shareholder Actions - CCC repurchased 4.8 million shares for approximately $44.9 million during Q3 2025, totaling 22.8 million shares repurchased year-to-date for $217.2 million[14] Market and Product Developments - A top-20 insurer adopted CCC's AI-enabled workflow solution, indicating strong demand for intelligent automation in the claims lifecycle[8] - The integration of EvolutionIQ's AI-powered medical record synthesis solution into CCC's casualty suite became generally available in Q3 2025[9] - The company acquired EvolutionIQ, Inc. for $410.41 million, impacting cash flows from investing activities significantly[24] Liabilities and Equity - Total current assets decreased to $330.68 million as of September 30, 2025, down from $564.65 million at the end of 2024[21] - Total liabilities increased to $1.46 billion as of September 30, 2025, compared to $1.16 billion at the end of 2024, representing a 25.7% increase[21] - The company’s total stockholders' equity increased to $2.13 billion as of September 30, 2025, compared to $1.99 billion at the end of 2024, reflecting a growth of 6.6%[21] Expenses - Research and development expenses for Q3 2025 were $52.95 million, an increase of 6.0% from $49.53 million in Q3 2024[22] - Operating expenses for Q3 2025 were $162,999,000, compared to $154,732,000 in Q3 2024, marking a rise of 5.8%[27] Margins - GAAP gross profit was $193.0 million with a gross margin of 72% in Q3 2025, down from a gross margin of 77% in Q3 2024[7] - The gross profit margin for Q3 2025 was 72%, down from 77% in Q3 2024[26] - The adjusted EBITDA margin for the nine months ended September 30, 2025, was 41%, slightly down from 42% in the same period of 2024[29]